<DOC>
	<DOCNO>NCT01149018</DOCNO>
	<brief_summary>The objective study evaluate effectiveness oral tetrahydrocannabinol patient suffer Fibromyalgia</brief_summary>
	<brief_title>Efficacy Trial Oral Tetrahydrocannabinol Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Adult ( &gt; 18y.o ) Patient Fibromyalgia , diagnose ACR criterion Children &lt; 18 year old Patients follow psychiatric disorder : Psychosis history acute psychosis Schizophrenia Bipolar disorder Patients smoke marijuana , use hashish form cannabis . Patients history drug abuse illicit drug use Patients receive chronic treatment strong opioids ( Morphine , Oxycodone , Fentanyl , Methadone , Hydromorphone , Buprenorphine , Pethidine ) . Weak opioids Tramadol Propoxyphene allow . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Tetrahydrocannabinol</keyword>
	<keyword>Chronic Widespread Pain</keyword>
</DOC>